Adage Capital Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-155,000
| Closed | -$8.39M | – | 904 |
|
|
2024
Q4 | $8.39M | Sell |
155,000
-350,000
| -69% | -$19M | 0.01% | 647 |
|
|
2024
Q3 | $25.5M | Sell |
505,000
-1,320,000
| -72% | -$66.6M | 0.05% | 392 |
|
|
2024
Q2 | $80.2M | Sell |
1,825,000
-459,913
| -20% | -$20.2M | 0.15% | 145 |
|
|
2024
Q1 | $115M | Buy |
2,284,913
+759,196
| +50% | +$38.1M | 0.22% | 95 |
|
|
2023
Q4 | $92.1M | Sell |
1,525,717
-426,986
| -22% | -$25.8M | 0.19% | 120 |
|
|
2023
Q3 | $111M | Buy |
1,952,703
+580,375
| +42% | +$33.1M | 0.25% | 86 |
|
|
2023
Q2 | $70M | Sell |
1,372,328
-296,543
| -18% | -$15.1M | 0.15% | 154 |
|
|
2023
Q1 | $35.7M | Buy |
+1,668,871
| New | +$35.7M | 0.08% | 287 |
|
|
2022
Q1 | – | Sell |
-1,011,589
| Closed | -$10M | – | 1112 |
|
|
2021
Q4 | $10M | Hold |
1,011,589
| – | – | 0.02% | 696 |
|
|
2021
Q3 | $10.1M | Hold |
1,011,589
| – | – | 0.02% | 680 |
|
|
2021
Q2 | $10.5M | Hold |
1,011,589
| – | – | 0.02% | 676 |
|
|
2021
Q1 | $10.3M | Hold |
1,011,589
| – | – | 0.02% | 664 |
|
|
2020
Q4 | $11.5M | Buy |
+1,011,589
| New | +$11.5M | 0.03% | 557 |
|